Jeffrey W. Henderson serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Henderson has been a member of the board since 2018.
Henderson is the president of JWH Consulting LLC, a business and investment advisory firm, focused primarily on the healthcare industry. He previously served as an advisory director to Berkshire Partners LLC, a private equity firm, from September 2015 to December 2019. Henderson served as chief financial officer of Cardinal Health Inc., a global healthcare products and services company, from May 2005 to November 2014. Prior to joining Cardinal Health, Henderson held multiple positions at Eli Lilly and General Motors, including international positions. He serves as a director of Qualcomm, Inc. and chair of the board of Halozyme Therapeutics, Inc. Henderson previously served on the board of FibroGen, Inc.
Henderson is an experienced healthcare executive who brings to the Board a deep knowledge of the industry, along with strong financial, strategic and operational expertise and significant international experience. He brings valuable corporate governance experience from his service as a director of other public companies.